Astragaloside IV attenuates gestational diabetes mellitus via targeting NLRP3 inflammasome in genetic mice

• Auteurs principaux: Ruixue Zhang (Auteur), Xuelei Zhang (Auteur), Baoheng Xing (Auteur), Jianyong Zhao (Auteur), Peipei Zhang (Auteur), Dandan Shi (Auteur), Fengzhen Yang (Auteur)
• Format: Livre
• Publié: BMC, 2019-09-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Abstract Background As the most ordinary metabolic disorder during pregnancy, gestational diabetes mellitus (GDM) has become a severe risk for the health of both pregnant female and fetus. Astragaloside IV (AS-IV) is the dominant active component in Astragalus membranaceus. It has been proved that A...